Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3 ILa | +7.14% | +7.14% | +15.38% |
May. 12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
May. 09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.38% | 11.37M | |
-0.28% | 90.59B | |
-0.92% | 38.99B | |
-9.57% | 34.09B | |
-17.98% | 15.02B | |
-6.74% | 13.17B | |
-9.76% | 11.88B | |
-47.31% | 10.65B | |
+7.57% | 9.25B | |
+137.06% | 9.02B |
- Stock Market
- Equities
- CANF Stock
- News Can-Fite BioPharma Ltd.
- Transcript : Can-Fite BioPharma Ltd. - Special Call